GeerlingsMI, JonkerC, BouterLM, et al.Association between memory complaints and incident Alzheimer's disease in elderly people with normal baseline cognition. Am J Psychiatry, 1999; 156:531–537.
2.
Harvard Health Publishing. Could those common symptoms be thyroid trouble? Fatigue, brain fog, and weight gain are telltale signs that may be mistaken for other conditions. Harvard Heal Lett, 2014; 39:6.
MusallamKM, TaherAT. Iron deficiency beyond erythropoiesis: Should we be concerned?. Curr Med Res Opin, 2018; 34:81–93.
5.
KillgoreWDS. Effects of sleep deprivation on cognition. In: KerkhofGA, van DongenHPA, eds. Progress in Brain Research. Amsterdam, Netherlands: Elsevier B.V., 2010:105–129.
6.
KovalchukA, KolbB. Chemo brain: From discerning mechanisms to lifting the brain fog—An aging connection. Cell Cycle, 2017; 16:1345–1349.
7.
UnderwoodEA, RochonPA, MoineddinR, et al.Cognitive sequelae of endocrine therapy in women treated for breast cancer: A meta-analysis. Breast Cancer Res Treat, 2018; 168:299–310.
8.
UnderwoodEA, JerzakKJ, LebovicG, et al.Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: A 1-year longitudinal study. Support Care Cancer, 2019; 27:3035–3043.
9.
GavaG, OrsiliI, AlvisiS, et al.Cognition, mood and sleep in menopausal transition: The role of menopause hormone therapy. Medicina (Kaunas), 2019; 55:668.
10.
MakiPM, HendersonVW. Cognition and the menopause transition. Menopause, 2016; 23:803–805.
11.
SilvaYP, BernardiA, FrozzaRL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Front Endocrinol (Lausanne), 2020; 11:25.
12.
ForbesJD, BernsteinCN, TremlettH, et al.A fungal world: Could the gut mycobiome be involved in neurological disease?. Front Microbiol, 2019; 10:3249.
13.
ZhangB, WangHE, BaiY-M, et al.Inflammatory bowel disease is associated with higher dementia risk: A nationwide longitudinal study. Gut, 2020; gutjnl-2020-320789.
14.
StrandwitzP. Neurotransmitter modulation by the gut microbiota. Brain Res, 2018; 1693:128–133.
15.
ShinW, KimHJ. Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci U S A, 2018; 115:E10539–E10547.
16.
NobleEE, HsuTM, KanoskiSE. Gut to brain dysbiosis: Mechanisms linking western diet consumption, the microbiome, and cognitive impairment. Front Behav Neurosci, 2017; 11:1–10.
17.
BonazB, BazinT, PellissierS. The vagus nerve at the interface of the microbiota-gut-brain axis. Front Neurosci, 2018; 12:49.
18.
AppletonJ. The gut-brain axis: Influence of microbiota on mood and mental health. Integr Med A Clin J, 2018; 17:28.
19.
PetersenC, RoundJL. Defining dysbiosis and its influence on host immunity and disease. Cell Microbiol, 2014; 16:1024–1033.
20.
GareauMG, WineE, RodriguesDM, et al.Bacterial infection causes stress-induced memory dysfunction in mice. Gut, 2011; 60:307–317.
21.
DukowiczAC, LacyBE, LevineGM. Small intestinal bacterial overgrowth: A comprehensive review. Gastroenterol Hepatol, 2007; 3:112–122.
RaoSSC, RehmanA, YuS, et al.Brain fogginess, gas and bloating: A link between SIBO, probiotics and metabolic acidosis article. Clin Transl Gastroenterol, 2018; 9:162.
24.
SachdevaS, PuriAS, KumarA, et al.Brain fogginess and SIBO: A link or just a mirage?. Clin Transl Gastroenterol, 2018; 9:184.
25.
Chaudhury. Cognitive impairments in chronic fatigue syndrome. Med J Dr DY Patil Univ, 2014; 7:422.
26.
Galvez-SánchezCM, Reyes del PasoGA, DuschekS. Cognitive impairments in Fibromyalgia syndrome: Associations with positive and negative affect, alexithymia, pain catastrophizing and self-esteem. Front Psychol, 2018; 9:377.
27.
YanceyJR, ThomasSM. Chronic fatigue syndrome: Diagnosis and treatment. Am Fam Physician, 2012; 86:741–746.
28.
WolfeF, ClauwDJ, FitzcharlesMA, et al.The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res, 2010; 62:600–610.
29.
KravitzHM, KatzRS. Fibrofog and fibromyalgia: A narrative review and implications for clinical practice. Rheumatol Int, 2015; 3:1115–1125.
30.
TesioV, TortaDME, ColonnaF, et al.Are fibromyalgia patients cognitively impaired? Objective and subjective neuropsychological evidence. Arthritis Care Res, 2015; 67:143–150.
31.
HuberA, SumanAL, BiasiG, et al.Alexithymia in fibromyalgia syndrome: Associations with ongoing pain, experimental pain sensitivity and illness behavior. J Psychosom Res, 2009; 66:425–433.
32.
WiseTN, MannLS. The relationship between somatosensory amplification, alexithymia, and neuroticism. J Psychosom Res, 1994; 38:515–521.
33.
StewartJA, Mailler-BurchS, MüllerD, et al.Rethinking the criteria for fibromyalgia in 2019: The ABC indicators. J Pain Res, 2019; 12:2115–2124.
34.
LatremoliereA, WoolfCJ. Central sensitization: A generator of pain hypersensitivity by central neural plasticity. J Pain, 2009; 10:895–926.
35.
MeeusM, NijsJ. Central sensitization: A biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol, 2007; 26:465–473.
36.
LangeG, DelucaJ, MaldjianJA, et al.Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome. J Neurol Sci, 1999; 171:3–7.
37.
De LangeFP, KoersA, KalkmanJS, et al.Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain, 2008; 131:2172–2180.
38.
LazaridouA, KimJ, CahalanCM, et al.Effects of cognitive-behavioral therapy (CBT) on brain connectivity supporting catastrophizing in fibromyalgia. Clin J Pain, 2017; 33:215–221.
39.
NiemannC, GoddeB, StaudingerUM, et al.Exercise-induced changes in basal ganglia volume and cognition in older adults. Neuroscience, 2014; 281:147–163.
40.
VerstynenTD, LynchB, MillerDL, et al.Caudate nucleus volume mediates the link between cardiorespiratory fitness and cognitive flexibility in older adults. J Aging Res, 2012; 2012:1–11.
41.
EtnierJL, KarperWB, GapinJI, et al.Exercise, fibromyalgia, and fibrofog: A pilot study. J Phys Act Heal, 2009; 6:239–246.
42.
HadjivassiliouM, GrünewaldR, SharrackB, et al.Gluten ataxia in perspective: Epidemiology, genetic susceptibility and clinical characteristics. Brain, 2003; 126:685–691.
43.
PollakTA, LennoxBR, MüllerS, et al.Autoimmune psychosis: An international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. Lancet Psychiatry, 2020; 7:93–108.
44.
JeppesenR, BenrosME. Autoimmune diseases and psychotic disorders. Front Psychiatry, 2019; 10:131.
45.
LebwohlB, LudvigssonJF. Editorial: ‘brain fog’ and coeliac disease—Evidence for its existence. Aliment Pharmacol Ther, 2014; 40:565–565.
46.
LichtwarkIT, NewnhamED, RobinsonSR, et al.Cognitive impairment in coeliac disease improves on a gluten-free diet and correlates with histological and serological indices of disease severity. Aliment Pharmacol Ther, 2014; 40:160–170.
MackayM. Lupus brain fog: A biologic perspective on cognitive impairment, depression, and fatigue in systemic lupus erythematosus. Immunol Res, 2015; 63:26–37.
49.
LynallM. Neuropsychiatric symptoms in lupus. Lupus, 2018; 27:18–20.
50.
KalimH, PratamaMZ, MahardiniE, et al.Accelerated immune aging was correlated with lupus-associated brain fog in reproductive-age systemic lupus erythematosus patients. Int J Rheum Dis, 2020; 23:620–626.
51.
AgarwalAK, GargR, RitchA, et al.Postural orthostatic tachycardia syndrome. Postgrad Med J, 2007; 83:478–480.
52.
AbdelRazekM, LowP, RoccaW, et al.Epidemiology of postural tachycardia syndrome. Neurology, 2019; 92:S18.005.
53.
ReichgottMJ. Clinical Evidence of Dysautonomia. Boston: Butterworths, 1990.
54.
BenarrochEE. Postural tachycardia syndrome: A heterogeneous and multifactorial disorder. Mayo Clin Proc, 2012; 87:1214–1225.
55.
RossAJ, MedowMS, RowePC, et al.What is brain fog? An evaluation of the symptom in postural tachycardia syndrome. Clin Auton Res, 2013; 23:305–311.
56.
RajV, HamanKL, RajSR, et al.Psychiatric profile and attention deficits in postural tachycardia syndrome. J Neurol Neurosurg Psychiatry, 2009; 80:339–344.
57.
WellsR, PatersonF, BacchiS, et al.Brain fog in postural tachycardia syndrome: An objective cerebral blood flow and neurocognitive analysis. J Arrhythmia, 2020; 36:549–552.
58.
RajV, OpieM, ArnoldAC. Cognitive and psychological issues in postural tachycardia syndrome. Auton Neurosci Basic Clin, 2018; 215:46–55.
59.
KomaroffAL. Inflammation correlates with symptoms in chronic fatigue syndrome. Proc Natl Acad Sci U S A, 2017; 114:8914–8916.
60.
GhoshalUC, ShuklaR, GhoshalU. Small intestinal bacterial overgrowth and irritable bowel syndrome: A bridge between functional organic dichotomy. Gut Liver, 2017; 11:196–208.
61.
RanaSV, SharmaS, KaurJ, et al.Relationship of cytokines, oxidative stress and GI motility with bacterial overgrowth in ulcerative colitis patients. J Crohn's Colitis, 2014; 8:859–865.
62.
YangT, YangY, WangD, et al.The clinical value of cytokines in chronic fatigue syndrome. J Transl Med, 2019; 17:213.
63.
WallaceDJ, Linker-IsraeliM, HalleguaD, et al.Cytokines play an aetiopathogenetic role in fibromyalgia: A hypothesis and pilot study. Rheumatology, 2001; 40:743–749.
64.
ManavalanJS, HernandezL, ShahJG, et al.Serum cytokine elevations in celiac disease: Association with disease presentation. Hum Immunol, 2010; 71:50–57.
65.
OkamotoLE, RajSR, GamboaA, et al.Sympathetic activation is associated with increased IL-6, but not CRP in the absence of obesity: Lessons from postural tachycardia syndrome and obesity. Am J Physiol Heart Circ Physiol, 2015; 309:H2098–H2107.
66.
WeinstockLB, BrookJB, MyersTL, et al.Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment. BMJ Case Rep, 2018; 2018:bcr-2017-221405.
67.
NewtonJL, OkonkwoO, SutcliffeK, et al.Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM, 2007; 100:519–526.
68.
OconAJ. Caught in the thickness of brain fog: Exploring the cognitive symptoms of Chronic Fatigue Syndrome. Front Physiol, 2013; 4:63.
69.
Martínez-LavínM. Fibromyalgia and small fiber neuropathy: The plot thickens! Clin Rheumatol 2018;37:3167–3171.
70.
VincentA, WhippleMO, LowPA, et al.Patients with fibromyalgia have significant autonomic symptoms but modest autonomic dysfunction. PM R, 2016; 8:425–435.
71.
HaghighatS, FatemiA, AndalibS. The autonomic dysfunction in patients with lupus disease: An electrophysiological study. Adv Biomed Res, 2016; 5:102.
PintérA, CsehD, SárköziA, et al.Autonomic dysregulation in multiple sclerosis. Int J Mol Sci, 2015; 16:16920–16952.
74.
AnanthakrishnanAN, IssaM, BarboiA, et al.Impact of autonomic dysfunction on inflammatory bowel disease. J Clin Gastroenterol, 2010; 44:272–279.
75.
SaffouriGB, Shields-CutlerRR, ChenJ, et al.Small intestinal microbial dysbiosis underlies symptoms associated with functional gastrointestinal disorders. Nat Commun, 2019; 10:2012.
76.
TomaselloG, MazzolaM, BoscoV, et al.Intestinal dysbiosis and hormonal neuroendocrine secretion in the fibromyalgic patient. Biomed Pap, 2018; 162:258–262.
77.
WallisA, BallM, ButtH, et al.Open-label pilot for treatment targeting gut dysbiosis in myalgic encephalomyelitis/chronic fatigue syndrome: Neuropsychological symptoms and sex comparisons. J Transl Med, 2018; 16:24.
78.
XuH, LiuM, CaoJ, et al.The dynamic interplay between the gut microbiota and autoimmune diseases. J Immunol Res, 2019; 2019:7546047.
79.
SheedyJR, WettenhallRE, ScanlonD, et al.Increased D-lactic acid intestinal bacteria in patients with Chronic Fatigue Syndrome. In Vivo (Brooklyn), 2009; 23:621–628.
80.
BaiW, ChenS, TangCS, et al.Gut microbiota analysis and its significance in vasovagal syncope in children. Chin Med J (Engl), 2019; 132:411–419.
81.
IshiiW, Komine-AizawaS, TakanoC, et al.Relationship between the fecal microbiota and depression and anxiety in pediatric patients with orthostatic intolerance. Prim Care Companion J Clin Psychiatry, 2019; 21:18m02401.
82.
TanAH, ChongCW, SongSL, et al.Altered gut microbiome and metabolome in patients with multiple system atrophy. Mov Disord, 2018; 33:174–176.
83.
McManimenS, McClellanD, StoothoffJ, et al.Dismissing chronic illness: A qualitative analysis of negative health care experiences. Health Care Women Int, 2019; 40:241–258.